Head & Neck Cancer Health Care Delivery Research Program

The primary goal of the MUSC/Hollings Cancer Center Head and Neck Cancer Healthcare Delivery Research Program is to understand the structure and processes of head and neck cancer care delivery so that we can develop theory-based, multilevel interventions targeting head and neck cancer care delivery pathways to improve survival and decrease racial disparities in outcomes in this patient population. We aim to improve our understanding of the mechanisms that underlie treatment delays and guideline non-adherent care among patients with head and neck cancer through several major lines of research:

  1. Characterizing the multilevel barriers to timely care among patients with head and neck cancer.
  2. Creating clinically-relevant risk prediction models for head and neck cancer patients and clinicians to predict treatment delays.
  3. Developing multilevel, theory-based interventions to decrease delays and racial disparities among patients with head and neck cancer.
  4. Developing and implementing technology-enhanced delivery platforms to improve access-to-care among patients with head and neck cancer.

Our multidisciplinary team of investigators is includes clinicians, psychologists, behavioral scientists, epidemiologists, and healthcare delivery researchers with expertise in head and neck cancer, cancer disparities, dissemination and implementation research, mHealth, patient navigation, population health, and clinical trials. Because patient-centered care is critical to our research program, our team includes patient advocates and supports patient and stakeholder engagement to extend the scientific and clinical impact of our research. This website provides information regarding the following:

  • Our Research Team
  • Select Publications
  • Research Support
  • Nomograms to Predict Treatment Delays
  • News Stories
  • Contact Us
  • Make a Gift

Clinical Trials

NDURE Study - Navigation for Disparities and Untimely Radiation Therapy

We are currently recruiting patients for the NDURE study, a trial funded by the National Cancer Institute to evaluate whether a new patient multilevel healthcare delivery intervention can decrease delays starting radiation therapy after surgery for white and African American head and neck cancer patients relative to standard care. Patients with head and neck cancer are eligible for this study. If you are interested, please contact Courtney Marsh at 843-876-1176 or marshch@musc.edu.